ClavystBio
Asia, Central Region, Singapore, Singapore'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Description
ClavystBio invest in early-stage ventures in the biotech, medtech and digital health sectors.
Investor Profile
ClavystBio has backed more than 9 startups, with 5 new investments in the last 12 months alone. The firm has led 4 rounds, about 44% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Seed rounds (top funding stages).
- Majority of deals are located in Singapore, United States, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 2 rounds in the past year.
Stage Focus
- Series A (44%)
- Series B (22%)
- Seed (11%)
- Series Unknown (11%)
- Series D (11%)
Country Focus
- Singapore (56%)
- United States (33%)
- The Netherlands (11%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Artificial Intelligence (Ai)
- Machine Learning
- Internet
- Health Diagnostics
- Life Science
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
